ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
4 NDCs across 2 manufacturers|2 Generic,2 Brand
Alogliptin and metformin hydrochloride is available as 4 NDCs from 2 manufacturers (2 generic, 2 brand), with NADAC prices from $2.20 to $6.59 per unit — a 67% spread. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
2G / 2B
Manufacturers
2
competing in market
Price Spread
$2.20 – $6.59
Up to 67% savings
7d Activity
avg +0.1% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Frequently Asked Questions
How many Alogliptin and metformin hydrochloride products are on the market?
The Alogliptin and metformin hydrochloride drug market contains 4 NDCs from 2 manufacturers — 2 generic and 2 brand products.
What is the price range for Alogliptin and metformin hydrochloride?
NADAC reference prices for Alogliptin and metformin hydrochloride range from $2.1976 to $6.5885 per unit, a 67% spread between the cheapest and most expensive product.
Is generic Alogliptin and metformin hydrochloride cheaper than brand?
The average generic NADAC for Alogliptin and metformin hydrochloride is $2.3433 per unit, versus $6.5770 for brand — generic is about 64% cheaper on average.
Which manufacturers make Alogliptin and metformin hydrochloride?
2 manufacturers list Alogliptin and metformin hydrochloride in NADAC. Ranked by number of NDCs, the largest are Takeda Pharmaceuticals America, Inc. (2), Padagis Israel Pharmaceuticals Ltd (2).
How has the price of Alogliptin and metformin hydrochloride changed recently?
Over the past 7 days, 2 Alogliptin and metformin hydrochloride NDCs rose and 2 fell, with a market-wide average change of +0.1%.
Manufacturer Breakdown
2 manufacturers producing ALOGLIPTIN AND METFORMIN HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KAZANO 12.5-500 MG TABLET | $6.5885 per EA | — |
KAZANO 12.5-1,000 MG TABLET | $6.5654 per EA | — |
ALOGLIPTIN-METFORMIN 12.5-1000 | $2.4891 per EA | -1.43% |
ALOGLIPTIN-METFORMIN 12.5-500 | $2.1976 per EA | +1.69% |